Date Field | Doc. No. | Description (Pages) |
---|
Aug 25, 2024 | 0 | REGENERON PHARMACEUTICALS, INC. v. MYLAN PHARMACEUTICALS INC. [ORDER] [nonprecedential] (0) |
Aug 20, 2024 | 28 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [25] filed by Appellant Regeneron Pharmaceuticals, Inc. in 24-1564. The appeals are dismissed. Each party shall bear its own costs for each appeal.; issuing mandate. Service as of this date by the Clerk of Court. [1026272] [24-1564, 24-1567] [NL] [Entered: 08/20/2024 11:37 AM] (2) |
Aug 12, 2024 | 27 | RESPONSE of Appellee Samsung Bioepis Co., Ltd. to Doc No. [25]. Service: 08/12/2024 by email. [1024356] [24-1564] [Raymond Nimrod] [Entered: 08/12/2024 05:47 PM] (7) |
Aug 5, 2024 | 25 | MOTION of Appellant Regeneron Pharmaceuticals, Inc. to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 08/05/2024 by email. [1022706] [24-1564] [Thomas Saunders] [Entered: 08/05/2024 12:21 PM] (5) |
Aug 5, 2024 | 26 | ORDER staying the briefing schedule. See Fed. Cir. R. 31(c). No later than 10 days following the date of entry of this order, Samsung Bioepis Co., Ltd. is directed to file a response to the motion [25] and should address allocation of costs. Service as of this date by the Clerk of Court. [1022890] [NL] [Entered: 08/05/2024 04:28 PM] (2) |
Jun 18, 2024 | 24 | ORDER granting motion to extend time to file brief [23] filed by Appellant Regeneron Pharmaceuticals, Inc. The opening brief is due 08/05/2024. Service as of this date by the Clerk of Court. [1011851] [LMS] [Entered: 06/18/2024 02:51 PM] (2) |
Jun 13, 2024 | 23 | MOTION of Appellant Regeneron Pharmaceuticals, Inc. to extend the time to 08/05/2024 to file brief. Service: 06/13/2024 by email. [1011022] [24-1564] [Thomas Saunders] [Entered: 06/13/2024 06:59 PM] (9) |
Apr 23, 2024 | 22 | Certified list received. Service: 04/22/2024 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [999437] [24-1564, 24-1567] [JSP] [Entered: 04/23/2024 12:50 PM] (185) |
Mar 29, 2024 | 18 | Entry of Appearance for Raymond N. Nimrod; Matthew A. Traupman as counsel for Appellee Samsung Bioepis Co., Ltd.. Service: 03/29/2024 by email. [993996] [24-1564] [Matthew Traupman] [Entered: 03/29/2024 09:32 PM] (1) |
Mar 29, 2024 | 19 | Docketing Statement for the Appellee Samsung Bioepis Co., Ltd.. Service: 03/29/2024 by email. [993997] [24-1564] [Matthew Traupman] [Entered: 03/29/2024 09:35 PM] (2) |
Mar 29, 2024 | 20 | Certificate of Interest for Appellee Samsung Bioepis Co., Ltd.. Service: 03/29/2024 by email. [993999] [24-1564] [Matthew Traupman] [Entered: 03/29/2024 09:44 PM] (3) |
Mar 29, 2024 | 21 | Notice of Related Case Information for Appellee Samsung Bioepis Co., Ltd.. Service: 03/29/2024 by email. [994002] [24-1564] [Matthew Traupman] [Entered: 03/29/2024 09:49 PM] (6) |
Mar 28, 2024 | 16 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Celltrion, Inc., Docketing Statement [14], is not in compliance with the rules of this court (see attached). Compliant document due on 04/04/2024. Service as of this date by the Clerk of Court. [993541] [IMH] [Entered: 03/28/2024 09:58 AM] (2) |
Mar 28, 2024 | 17 | Corrected Docketing Statement for the Appellee Celltrion, Inc.. Service: 03/28/2024 by email. [993619] [24-1564] [Lora Green] [Entered: 03/28/2024 01:33 PM] (2) |
Mar 27, 2024 | 4 | Entry of Appearance for Thomas G. Saunders; Lauren Matlock-Colangelo; Deborah E. Fishman; Abigail Struthers as counsel for Appellant Regeneron Pharmaceuticals, Inc.. Service: 03/27/2024 by email. [993288] [24-1564] [Thomas Saunders] [Entered: 03/27/2024 10:18 AM] (2) |
Mar 27, 2024 | 5 | Certificate of Interest for Appellant Regeneron Pharmaceuticals, Inc.. Service: 03/27/2024 by email. [993289] [24-1564] [Thomas Saunders] [Entered: 03/27/2024 10:19 AM] (3) |
Mar 27, 2024 | 6 | Notice of Related Case Information for Appellant Regeneron Pharmaceuticals, Inc.. Service: 03/27/2024 by email. [993291] [24-1564] [Thomas Saunders] [Entered: 03/27/2024 10:19 AM] (6) |
Mar 27, 2024 | 7 | Docketing Statement for the Appellant Regeneron Pharmaceuticals, Inc.. Service: 03/27/2024 by email. [993293] [24-1564] [Thomas Saunders] [Entered: 03/27/2024 10:20 AM] (2) |
Mar 27, 2024 | 8 | Entry of Appearance for William A. Rakoczy; Heinz J. Salmen; Paul J. Molino; Deanne M. Mazzochi; Eric R. Hunt; Lauren M. Lesko; Neil B. McLaughlin as counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 03/27/2024 by email. [993494] [24-1564] [William Rakoczy] [Entered: 03/27/2024 10:30 PM] (2) |
Mar 27, 2024 | 9 | Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 03/27/2024 by email. [993495] [24-1564] [William Rakoczy] [Entered: 03/27/2024 10:34 PM] (5) |
Mar 27, 2024 | 10 | Notice of Related Case Information for Appellee Mylan Pharmaceuticals Inc.. Service: 03/27/2024 by email. [993496] [24-1564] [William Rakoczy] [Entered: 03/27/2024 10:36 PM] (6) |
Mar 27, 2024 | 11 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 03/27/2024 by email. [993497] [24-1564] [William Rakoczy] [Entered: 03/27/2024 10:39 PM] (2) |
Mar 27, 2024 | 12 | Certificate of Interest for Appellee Celltrion, Inc.. Service: 03/27/2024 by email. [993499] [24-1564] [Lora Green] [Entered: 03/27/2024 11:29 PM] (3) |
Mar 27, 2024 | 13 | Entry of Appearance for Lora M. Green; Robert Cerwinski as counsel for Appellee Celltrion, Inc.. Service: 03/27/2024 by email. [993500] [24-1564] [Lora Green] [Entered: 03/27/2024 11:53 PM] (1) |
Mar 27, 2024 | 14 | Docketing Statement for the Appellee Celltrion, Inc.. Service: 03/27/2024 by email. [993501] [24-1564] This document is non-compliant. See Doc No.[16] [Lora Green] [Entered: 03/27/2024 11:55 PM] (2) |
Mar 27, 2024 | 15 | Notice of Related Case Information for Appellee Celltrion, Inc.. Service: 03/27/2024 by email. [993502] [24-1564] [Lora Green] [Entered: 03/27/2024 11:58 PM] (6) |
Mar 25, 2024 | 2 | ORDER consolidating appeals (24-1564, 24-1567). The Certified Lists are due no later than April 22, 2024.. Service as of this date by the Clerk of Court. [992679] [24-1564, 24-1567] [JSP] [Entered: 03/25/2024 12:35 PM] (2) |
Mar 25, 2024 | 3 | Note to File: The following cases are consolidated: 24-1564 Lead with 24-1567 Member appeal. The parties must file all documents in the lead appeal only. [992680] [24-1564, 24-1567] [JSP] [Entered: 03/25/2024 12:36 PM] (0) |
Mar 13, 2024 | 1 | Appeal docketed. Received: 03/12/2024. [990362] Entry of Appearance is due on 03/27/2024. Certificate of Interest is due on 03/27/2024. Docketing Statement is due on 03/27/2024. Certified List is due on 04/22/2024. [JSP] [Entered: 03/13/2024 11:08 AM] (0) |